What’s in Codexis, Inc. (CDXS) After Achieving 52-Week High?

May 16, 2018 - By Betty Noble

Codexis, Inc. (NASDAQ:CDXS) Logo

Investors sentiment decreased to 2.17 in Q4 2017. Its down 0.03, from 2.2 in 2017Q3. It is negative, as 3 investors sold Codexis, Inc. shares while 15 reduced holdings. 12 funds opened positions while 27 raised stakes. 28.02 million shares or 9.42% more from 25.60 million shares in 2017Q3 were reported.
Cortina Asset Mngmt Limited Liability Co reported 1.01 million shares. Credit Suisse Ag stated it has 0% of its portfolio in Codexis, Inc. (NASDAQ:CDXS). Bancshares Of New York Mellon stated it has 0% of its portfolio in Codexis, Inc. (NASDAQ:CDXS). Goldman Sachs Grp Incorporated invested in 41,931 shares or 0% of the stock. Opaleye Inc has invested 4.55% in Codexis, Inc. (NASDAQ:CDXS). Laurion Mngmt Ltd Partnership stated it has 0% in Codexis, Inc. (NASDAQ:CDXS). Parallax Volatility Advisers L P holds 0% of its portfolio in Codexis, Inc. (NASDAQ:CDXS) for 6,594 shares. 804,224 are owned by First Light Asset Mgmt Limited Liability. Perkins holds 0.24% of its portfolio in Codexis, Inc. (NASDAQ:CDXS) for 30,000 shares. Guggenheim Cap Ltd Liability Corporation holds 10,184 shares. Legal And General Grp Public Limited Com has invested 0% in Codexis, Inc. (NASDAQ:CDXS). Strs Ohio holds 0% of its portfolio in Codexis, Inc. (NASDAQ:CDXS) for 88,800 shares. Moreover, Tiaa Cref Invest Management Ltd Liability has 0% invested in Codexis, Inc. (NASDAQ:CDXS) for 97,385 shares. National Bank Of Montreal Can holds 1,324 shares. Manufacturers Life Insurance The accumulated 0% or 32,689 shares.

Since March 21, 2018, it had 0 buys, and 5 selling transactions for $1.19 million activity. NICOLS JOHN J sold $259,828 worth of stock or 22,465 shares. WOLF DENNIS P also sold $464,384 worth of Codexis, Inc. (NASDAQ:CDXS) shares. $62,213 worth of stock was sold by Smith David V on Tuesday, April 3. 10,206 Codexis, Inc. (NASDAQ:CDXS) shares with value of $124,683 were sold by KELLEY BERNARD J.

The stock of Codexis, Inc. (NASDAQ:CDXS) hit a new 52-week high and has $14.43 target or 4.00 % above today’s $13.88 share price. The 9 months bullish chart indicates low risk for the $738.71 million company. The 1-year high was reported on May, 16 by Barchart.com. If the $14.43 price target is reached, the company will be worth $29.55M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 4.72% or $0.625 during the last trading session, reaching $13.875. About 229,299 shares traded. Codexis, Inc. (NASDAQ:CDXS) has risen 125.77% since May 16, 2017 and is uptrending. It has outperformed by 114.22% the S&P500.

Analysts await Codexis, Inc. (NASDAQ:CDXS) to report earnings on August, 8. They expect $-0.03 earnings per share, up 76.92 % or $0.10 from last year’s $-0.13 per share. After $-0.10 actual earnings per share reported by Codexis, Inc. for the previous quarter, Wall Street now forecasts -70.00 % EPS growth.

Codexis, Inc. (NASDAQ:CDXS) Ratings Coverage

Among 2 analysts covering Codexis (NASDAQ:CDXS), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Codexis has $1600 highest and $11.5 lowest target. $13.75’s average target is -0.90% below currents $13.875 stock price. Codexis had 2 analyst reports since March 12, 2018 according to SRatingsIntel. The stock of Codexis, Inc. (NASDAQ:CDXS) has “Buy” rating given on Monday, March 12 by H.C. Wainwright. Stephens initiated Codexis, Inc. (NASDAQ:CDXS) rating on Wednesday, May 16. Stephens has “Buy” rating and $1600 target.

More important recent Codexis, Inc. (NASDAQ:CDXS) news were published by: Globenewswire.com which released: “Codexis to Hold First Quarter 2018 Conference Call on May 10” on May 03, 2018, also Nasdaq.com published article titled: “3 High-Growth Stocks That Are Just Getting Started”, Seekingalpha.com published: “Codexis’ (CDXS) CEO John Nicols on Q1 2018 Results – Earnings Call Transcript” on May 11, 2018. More interesting news about Codexis, Inc. (NASDAQ:CDXS) was released by: Globenewswire.com and their article: “Codexis Reports First Quarter 2018 Financial Results” with publication date: May 10, 2018.

Codexis, Inc. discovers, develops, and sells protein catalysts. The company has market cap of $738.71 million. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable clients to perform chemistry screening. It currently has negative earnings. The firm also provides protein catalyst screening and protein engineering services.

Codexis, Inc. (NASDAQ:CDXS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.